J. C. Schwamborn

The paper introduces a scalable organ-on-chip platform for high-throughput in vitro assays, demonstrating its use in modeling biological barriers and drug testing.

This study develops a multi-sensor organ-on-a-chip platform to monitor Parkinson's disease-related phenotypes in midbrain organoids and demonstrates its utility in drug screening.

This study shows PARK7/DJ-1 enhances PDH activity in Tregs by inhibiting PDHA phosphorylation, maintaining Treg homeostasis and reducing EAE severity.

This study develops a sensor-integrated microfluidic platform for long-term cultivation and non-invasive monitoring of human midbrain organoids, showing sustained viability and dopaminergic differentiation over 50 days.

The paper develops a midbrain organoid system to model Parkinson's disease and introduces a machine learning pipeline for neurotoxicity prediction using high-content imaging data.

The paper develops a high-throughput platform for automated analysis of autophagy and mitophagy pathway intermediates using high-content image analysis.